Advances in Vasodilatory Shock:
Objectives
Defining Shock
Classification of Shock/Various Causes
Causes of Vasodilatory Shock
Final Common Pathway
What Happens in VS?
Hemodynamics in VS
Systems Involved In Restoring Effective Blood Pressure
Goals of Treatment For VS
Surviving Sepsis Campaign: Initial Resuscitation
Blood Lactate as a Predictor of Survival
Dynamic Fluid Assessment in Goal-Directed Therapy
Surviving Sepsis Campaign: Fluid Therapy
SAFE Trial: Albumin vs Saline Resuscitation
ALBIOS: Albumin Replacement in Patients With Severe Sepsis/Septic Shock
Gelatin vs Crystalloids and Albumin in Patients With Hypovolemia
Surviving Sepsis Campaign: Vasoactive Medications
Brief History of Vasopressors
Dopamine vs Norepinephrine for the Treatment of Critically Ill
Dopamine vs Norepinephrine for the Treatment of Septic Shock
Epinephrine vs Norepinephrine for the Treatment of Critically Ill
Vasopressin vs Norepinephrine for the Treatment of Septic Shock
Vasopressin vs Terlipressin for the Treatment of Vasodilatory Shock
Refractory Vasodilatory Shock and Angiotensin II
Angiotensin II Trials
ATHOS-3: Primary Outcome
ATHOS-3: Additional Endpoints
Angiotensin II: Current Status
V1a Agonist in Patients With Septic Shock
Still Evolving…
Take Home Points
Abbreviations
Abbreviations (cont)
Abbreviations (cont)
Abbreviations (cont)